1. Combination of High-Dose Parenteral Ascorbate (Vitamin C) and Alpha-Lipoic Acid Failed to Enhance Tumor-Inhibitory Effect But Increased Toxicity in Preclinical Cancer Models
   Ping Chen et al, 2024, Clinical Medicine Insights: Oncology CrossRef
2. Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
   Ping Chen et al, 2022, Clinical Pharmacokinetics CrossRef
3. Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer
   Francisco Quiñonero et al, 2023, International Journal of Nanomedicine CrossRef
4. Quantitative Analysis of the Efficacy of PARP Inhibitors as Maintenance Therapy in Recurrent Ovarian Cancer
   Lili Gao et al, 2021, Frontiers in Pharmacology CrossRef
5. High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients
   Manuela Giansanti et al, 2021, Cancers CrossRef
6. Niraparib plays synergistic antitumor effects with NRT in a mouse ovarian cancer model with HRP
   Jiefang Lu et al, 2024, Translational Oncology CrossRef